There are no limits to your wardrobe after breast cancer surgery thanks to strapless mastectomy bras.

Dr. Brendan Gaylis with the Scripps MD Anderson Cancer Center & Scripps Clinic talks to ABC 10News about Oral Cancer Awareness Month and the link to HPV.

In this video, Mackenzie Boedicker and Dr. Betsy Mencher (caregiver for her husband) share their experiences and discuss the importance of an early and accurate diagnosis of amyloidosis.

Cristina Mutchler reports on a cancer survivor who's spreading the gospel of exercise.

Special thank you to Shraya Pandya for reviewing this script!

In this video you will revise everything a medical student needs to know about prostate cancer and its management...

Recap the anatomy and function of the prostate
Risk factors
Signs/symptoms
Investigations
Staging
Treatment options
Prostate cancer screening

Enjoy!

*Disclaimer: this video is purely for educational purposes, and does not subs****ute professional medical advice or consultations with healthcare professionals.*

This video should be used with the drain section of “Your Journey Through Breast Cancer Surgery” booklet or health topic on MyHealth.Alberta.ca (myhealth.alberta.ca/breast-cancer-surgery/at-home/drain-care). It describes the steps of caring for the drain and the drain site in the first 1-2 weeks after a mastectomy (breast surgery).

Luis Malpica Castillo, MD, Assistant Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses cutaneous T-cell lymphoma (CTCL) and the challenges of treating people of color.

Cutaneous T-cell lymphoma (CTCL) belongs to the non-Hodgkin lymphoma class of hematologic T-cell lymphoproliferative disorders. Cutaneous T-cell lymphoma is a rare group of malignancies, with an incidence of 6.4 cases per 1 million people. This form of T-cell lymphoma represents around 70% of primary cutaneous lymphomas.

Cutaneous T-cell lymphoma attacks the the body’s immune system, specifically, the lymphatic system, affecting the two types of white blood cells (lymphocytes): B-cells and T-cells. Whereas the B-lymphocytes act to neutralize the pathogens, the main job of the T-lymphocytes is to attach to these foreign cells, viruses, or cancerous growths, and directly destroy them.

Compared with other T-cell lymphomas, a distinguishing feature of CTCL is implied by the name: malignant T-cells migrating to, and collecting in, cutaneous tissue. Diagnosis can be challenging, because the initial signs and symptoms are largely skin-related and overlap with those of many other dermatologic disorders. Adding to the challenge, CTCL variants present with overlapping symptomatology, and correct identification of the CTCL subtype is key to both treatment and prognosis. Histopathologic features must be correlated with the clinical presentation to confirm the diagnosis.

Many forms of CTCL are relatively indolent compared with other T-cell lymphomas, but there are aggressive subtypes. This is illustrated by the two most common forms of CTCL: mycosis fungoides and Sézary syndrome. Although mycosis fungoides is considered a slow-growing variant, Sézary syndrome is aggressive and generally has a poor prognosis. Importantly, even the indolent subtypes can progress in some patients and become difficult to manage.

Dr. Trisha Scharff discusses quality of life in cutaneous T-cell lymphoma, specifically mycosis fungoides and Sézary syndrome. Dr. Scharff explains what health-related quality of life (HRQoL) and patient-reported outcomes (PROs) are, what they reveal and their value.

Clinician:
Trisha Scharff, MD, MPHS
Washington University School of Medicine

One year after voluntarily recalling textured breast implants shown to have a potential link to cancer, Allergan is making a new push to track down thousands of women who may not be aware of the risk.